Skip to main content

QUEST DIAGNOSTICS INC

For the period ended Mar 31, 2025. Filed Apr 23, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed Apr 23, 2025

DGX$255.63+0.3%Stored close · as of Nov 6, 2026

What changed in Risk Factors?

Read the current filing

Previous report: 10-Q

Period ended 2024-09-30; filed 2024-10-23.

0001022079-24-000190

Item 1A. Risk Factors

Current report: 10-Q

Period ended 2025-03-31; filed 2025-04-23.

0001022079-25-000120

Item 1A. Risk Factors

The baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.

Compared 4 previous paragraphs and 3 current paragraphs.

2 unchanged; 1 reworded; 0 added; 1 removed; 0 previous and 0 current paragraphs rearranged.

Tables are not compared: 1 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.

A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.

Removed paragraphs (1)

Previous report

Item 1A. of our Annual Report on Form 10-K for the year ended December 31, 2023 and Part II, Item 1A. of our Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 include a discussion of our risk factors. There have been no material changes in the risk factors described in those reports.
Reworded paragraphs (1)

Previous wording

The table below sets forth the information with respect to purchases made by or on behalf of the Company of its common stock during the third quarter of 2024.

Current wording

The table below sets forth the information with respect to purchases made by or on behalf of the Company of its common stock during the first quarter of 2025.